Innovation and improvement in the treatment of obesity and diabetes.
作者信息
Ryder S W
出版信息
Clin Pharmacol Ther. 2007 May;81(5):615-9. doi: 10.1038/sj.clpt.6100189.
PMID:17438532
Abstract
摘要
相似文献
1
Innovation and improvement in the treatment of obesity and diabetes.肥胖症和糖尿病治疗方面的创新与改进。
Clin Pharmacol Ther. 2007 May;81(5):615-9. doi: 10.1038/sj.clpt.6100189.
2
Epidemiologic and economic consequences of the global epidemics of obesity and diabetes.肥胖症和糖尿病全球流行的流行病学及经济后果。
Nat Med. 2006 Jan;12(1):62-6. doi: 10.1038/nm0106-62.
3
4
Addressing obesity via diabetes self-management education and training.通过糖尿病自我管理教育与培训来解决肥胖问题。
Diabetes Educ. 2012 Jan-Feb;38(1):151-4. doi: 10.1177/0145721711433758.
5
Feeding the threat.助长威胁。
Bus Health. 2001;19(10 Suppl B):4-5.
6
The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?肥胖、糖尿病与高血压争议（CODHy）会议：究竟是关于什么的？
Diabetes Care. 2008 Feb;31 Suppl 2:S111-2. doi: 10.2337/dc08-s226.
7
Obesity and diabetes: the roles that prices and policies play.
Adv Health Econ Health Serv Res. 2007;17:113-28.
8
Health plans are ill-prepared for looming diabetes epidemic.医疗保健计划对即将到来的糖尿病流行准备不足。
Manag Care. 2006 May;15(5):24-5, 28-30, 36.
9
Ten-year comparison of estimates of overweight and obesity, diagnosed diabetes and use of office-based physician services for treatment of diabetes in the United States.美国超重和肥胖估计值、确诊糖尿病以及使用门诊医生服务治疗糖尿病的十年对比。
Prev Med. 2007 Nov;45(5):353-7. doi: 10.1016/j.ypmed.2007.07.018. Epub 2007 Jul 24.
10
Americans are living longer, but obesity and diabetes are rising.美国人寿命在延长，但肥胖和糖尿病问题却在增加。
BMJ. 2011 Feb 18;342:d1143. doi: 10.1136/bmj.d1143.
引用本文的文献
1
Therapeutic Apheresis in Metabolic Syndrome.代谢综合征中的治疗性血液成分分离术
Immunol Endocr Metab Agents Med Chem. 2018 May;18(1):38-54. doi: 10.2174/1871522218666180608114536.
Zotero 插件